T he H5N1 influenza A viruses are considered to be potential progenitors of a new influenza pandemic. [1] [2] [3] [4] [5] [6] H5N1 disease is much more severe in humans than infection with seasonal human-adapted H1N1 or H3N2 influenza A virus strains, and the disease course differs in many aspects. [1] [2] [3] [4] [5] [6] Ocular involvement in influenza A virus is common but is usually limited to mild conjunctivitis. [7] [8] [9] Cases of granulomatous iridocyclitis or diseases of the posterior segment of the eye such as inflammation of the choriocapillaris with subsequent atrophia of the retinal pigment epithelium (RPE) are much rarer. 7 Ocular symptoms during influenza infection are commonly reversible, for except influenza-induced degeneration of the RPE. 7 The RPE is a constituent of the blood-retina barrier that is essential for the maintenance of the immune privilege of the eye. 10 The inner blood-retina barrier consists of microvascular endothelial cells and the outer blood-retina barrier consists of RPE cells. 10 Notably, cases of influenza retinitis have been described in humans, especially in the context of influenza-caused central nervous system (CNS) disease. [11] [12] [13] [14] Detection of influenza virus RNA in cerebrospinal fluid (CSF) and brain tissues of influenza patients who have encephalitis/encephalopathy 15, 16 suggests a contribution of viral damage to these diseases. However, there is no information about influenza virus replication in the retina.
Notably, H5N1 influenza strains appear to have a greater potential to spread to nonrespiratory tissues than do seasonal "human" influenza viruses.
2 H5N1 infection of humans may result in systemic infection including the CNS. [17] [18] [19] In H5N1-infected mute swans, virus antigene was detected in the retina including the RPE. 20 The presence of H5N1 in the retina of humans has not been investigated yet.
We established primary human RPE cell cultures to study the replication of viruses in a relevant cell culture model derived from the retina. 10, [21] [22] [23] [24] [25] [26] In the present study, replication of avian H5N1 influenza A virus strains and seasonal human-adapted H3N2 and H1N1 influenza A virus strains were investigated in RPE cells.
MATERIALS AND METHODS

Drugs
Ribavirin (Virazole) was obtained from Valeant Pharmaceuticals GmbH (Eschborn, Germany). Interferon ␣-2B (Intron A) was purchased from Essex Pharma (Munich, Germany). Interferon ␤ (Fiblaferon) was received from Rentschler Biotechnologie (Laupheim, Germany). Interferon-␥1b (Imukin) was obtained from Boehringer Ingelheim (Ingelheim-am-Rhein, Germany). Interferon-␤1a (Avonex) was purchased from Biogen IDEC (Maidenhead, UK). determined as 50% tissue culture infectious dose (TCID 50 /mL; 50% tissue culture infectious dose/milliliter) in confluent Vero cells in 96-well microtiter plates.
Cells
RPE cells were isolated from three donors and cultured as described previously. 21 Briefly, the corneoscleral disc was removed first, followed by the lens and vitreous. The residual eye cup was sectioned with a longitudinal incision toward the optic nerve. Repeated rinsing with Ca 2ϩ and Mg 2ϩ Dulbecco's PBS allowed prompt separation of the remaining vitreous and neural retina from the layer of RPE and permitted detachment of the choroid from the sclera. The RPE cells adhering to Bruch's membrane on the choroidal sheets obtained were washed with PBS and treated with 0.25% trypsin-EDTA solution. Detached cells were resuspended in IMDM, supplemented with 20% FBS, and transferred to 25 cm 2 flasks. The homogeneity of cultured RPE cells was confirmed by positive immunostaining with mAb to cytokeratins (Pan) and to cellular retinaldehyde binding protein (mAbs were donated by John Saari, Department of Ophthalmology, University of Washington, School of Medicine, Seattle, WA). 27 The cell cultures used in this study were routinely tested for mycoplasma and were not used in the experiments later than passage 3.
A549 cells (human lung carcinoma; ATCC: CCL-185) were grown at 37°C in minimal essential medium (MEM) supplemented with 10% FBS, 100 IU/mL of penicillin, and 100 g/mL streptomycin.
Immune Staining
Cells were fixed with 40:60 acetone/methanol for 15 minutes. For detection of influenza A nucleoprotein, the monoclonal antibody MsX Influenza A (Chemicon, Hofheim, Germany) was used as the primary antibody. Activated caspase-3 and the 85-kDa fragment of cleaved poly(ADP-ribose) polymerase (PARP) were detected by the use of the following primary antibodies: caspase-3 (active; R&D Systems, Wiesbaden, Germany) and PARP p85-fragment (Promega, Mannheim, Germany). Biotin-conjugated secondary monoclonal antibodies were used and visualization was performed with streptavidin-peroxidase complex with 3-amino-9-ethylcarbazole as the substrate.
Electron Microscopy
Cells were processed for ultrastructural analysis, as described previously. 22 Briefly, cells were pelleted and fixed with 2.5% glutaraldehyde, postfixed in 1% osmium tetroxide, dehydrated in ethanol and embedded in Durupan-Epon. Thin sections were contrasted with uranyl acetate and lead citrate and viewed with an electron microscope (JEM, 2000 CX; JEOL, Arishima, Japan).
Cytopathogenic Effect Reduction Assay
The cytopathogenic effect (CPE) reduction assay was performed as described before. 25 Confluent RPE monolayer grown in 96-well microtiter plates were infected with influenza A strains in the presence or absence of the investigated agents. The virus-induced CPE was recorded at 48 hours post infection (p.i.) with an inverted light microscope.
Real-Time PCR
Total RNA was isolated from cell cultures (TRI reagent; Sigma-Aldrich, Munich, Germany). Gene expression on the mRNA level was detected (TaqMan Gene Expression Assays; Applied Biosystems, Darmstadt, Germany) according to the manufacturer's instruction.
Real time PCR for H5 was performed according to published methods. 23 The following primers were used: sense 5Ј acg tat gac tac ccg cag tat tca g 3Ј; antisense 5Ј aga cca gcy acc atg att gc 3Ј; probe 6-FAM-tca aca gtg gcg agt tcc cta gca-TAMRA.
RESULTS
Influenza A Virus Replication in RPE Cells
In Immune staining for influenza A nucleoprotein revealed infection of all H5N1 A/Thailand/1(Kan-1)/04 (MOI 0.01)-infected RPE cells, whereas only a very few cells were found to be infected after infection with H1N1 (MOI 0.01; Fig. 1C ). Cells were infected at MOI 1 (Table 1) , to investigate whether reduced replication of seasonal influenza A virus strains may be caused by low (H3N2) or no (H1N1) ability of seasonal influenza A virus strains to infect RPE cells; 100% of the cells stained positively for influenza A nucleoprotein at 48 hours after infection with all viruses except H1N1 (84. 42 Ϯ 6.22) . This result suggests that seasonal influenza A virus strains are able to infect RPE cells but cannot complete full replication cycles.
The described experiments were performed in the absence of trypsin. Addition of trypsin did not significantly alter results. RPE cultures derived from the retina of two other donors showed similar sensitivity to influenza A virus infection (data not shown).
Apoptosis Induction by H5N1 Influenza Virus Infection in RPE Cells
Apoptosis induction is thought to play a role in H5N1 pathogenesis. 18 H5N1 viruses have been shown to induce apoptosis in different cell types including pneumocytes, immune cells, and CNS cells.
18,28 -32 H5N1-induced apoptosis was detected in RPE cells by immune staining. The number of apoptotic cells was determined by immune staining for activated caspase 3 or cleaved PARP by counting the positively stained cells in the central fields of three different wells (3.7 mm 2 ) of 96-well plates at 50ϫ magnification. Cells that stained positively for activated caspase-3 or cleaved PARP 48 hours p.i. with the H5N1 virus strain A/Thailand/1(Kan-1)/04 (MOI 0.01) were quantified relative to noninfected cells. H5N1 (A/Thailand/ 1(Kan-1)/04) infection resulted in a substantial increase in the number of apoptotic cells (Fig. 2) .
Since it is consistently active against a broad number of influenza viruses, 33 ribavirin is commonly used for inhibition of influenza replication in experimental settings, although it is not clinically approved for the treatment of influenza. The ribavirin concentration that inhibited 50% of H5N1 A/Thailand/1(Kan-1)/04 virus-induced CPE formation (IC 50 ) was 4.8 Ϯ 2.1 g/mL. Ribavirin 20 g/mL treatment suppressed H5N1-induced apoptosis in RPE cells (Fig. 2) indicating that virus replication is necessary for apoptosis induction. Similar results were obtained for the H5N1 strain A/Vietnam/1203/04 (data not shown).
Electron microscopic examination of H5N1 A/Thailand/ 1(Kan-1)/04-infected RPE cells revealed that apoptosis is induced in H5N1 virus producing RPE cells (Fig. 2) as indicated by membrane blebbing and nuclear fragmentation. Interferons were shown to be active against influenza virus infection and are discussed as potential anti-influenza drugs in case of an H5N1 pandemic. 34 -37 Therefore, antiviral effects of type I interferon-␣ and -␤ or type II interferon-␥ were studied in RPE cells. Pretreatment for 24 hours with all three interferons protected RPE cells from H5N1 A/Thailand/1(Kan-1)/04 virus-induced CPE in a concentration-dependent manner (Fig. 3A) . The lowest IC 50 s were obtained for interferon-␥ (43.0 Ϯ 26.9) and interferon-␤ (84.6 Ϯ 37.6; Fiblaferon; Rentschler Biotechnologie) ( Table 2) . Effects comparable to those detected for interferon-␤ were induced by interferon-␤1a (Avonex; Biogen IDEC) (data not shown). A549 lung cancer cells resemble human alveolar type II epithelial cells. IC 50 s for the type I interferons were lower in A549 cells, whereas IC 50 s for interferon-␥ were higher in A549 cells than in RPE cells ( Fig. 3 ; Table 2 ). (Fig. 4) . Ribavirin inhibited expression of the influenza H5 gene (indicating its influence on H5N1 replication) and of proinflammatory genes in H5N1 (A/Thailand/1(Kan-1)/04)-infected RPE cells in a dose-dependent manner (Fig. 5) . 
Influence of H5N1
DISCUSSION
This is the first report in which influenza A virus replication in human RPE cells was investigated. RPE cells represent a neuronal cell type that may be relevant in influenza A virus-induced retinal pathogenesis. [11] [12] [13] [14] 20 Influenza A virus replication was investigated in primary RPE cell cultures. The seasonal humanadapted influenza A strains A/New Caledonia/20/99 (H1N1) and A/California/7/2004 (H3N2) did not or only very slightly replicated in this cell type. In contrast, the highly pathogenic H5N1 avian influenza strains A/Thailand/1(Kan-1)/04, A/Vietnam/1203/04, and A/Vietnam/1194/04 replicated to high titers (Ͼ10 8 TCID 50 /mL) in RPE cells. RPE cultures were sensitive to infection (MOI 1) with seasonal influenza A viruses (80 -100% of infected cells) or H5N1 viruses (100% of infected cells). These findings do not reflect the differences detected in the production of infectious virus. Therefore, seasonal influenza A viruses and H5N1 viruses obviously possess different abilities to perform complete replication cycles in RPE cells. The observation that H5N1 viruses have a greater potential to replicate in RPE cells than do seasonal influenza A strains is in accordance with findings that suggest H5N1 influenza strains to have a greater potential to replicate in nonrespiratory tissues, including the CNS, than seasonal influenza viruses. 2, [17] [18] [19] Of note, influenza retinitis has been correlated to influenza CNS disease. [11] [12] [13] [14] Therefore, the ability to infect RPE cells may be limited to a (small) subset of seasonal CNS-tropic influenza A virus strains. Taking into account the higher CNS tropism of H5N1 strains, the spread of H5N1 infection in humans may result in an increase in cases of influenza A virus retinitis.
The permissiveness of RPE cells to influenza A virus infection correlated with the virus' ability to induce apoptosis. Infection (MOI 0.01) with H5N1 resulted in substantial apopto- 
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IOVS (Fig. 2) , whereas no (H1N1) or low (H3N2) apoptosis was detected, RPE cells were infected with seasonal virus strains (data not shown). Electron microscopic investigations confirmed apoptosis in H5N1 virus-producing RPE cells. Inhibition of virus replication by ribavirin also abrogated virus-induced apoptosis indicating apoptosis to be a consequence of virus replication. Apoptosis was detected in the lungs (in alveolar epithelial cells and leukocytes), in the spleen, and in intestinal tissues of humans who died of H5N1 disease. Therefore, induction of apoptosis may contribute to the organ injury observed in patients with H5N1. Caspase 3 activation had been shown to be crucial for efficient influenza A virus replication. 38, 39 Moreover, H5N1 infection induced apoptosis mainly via the caspasedependent pathway in human airway epithelial cells. 29, 39 Of note, others have reported that H1N1 and H3N2 strains with similar levels of replication may differ considerably in their ability to induce apoptosis and caspase 3 activation. 40, 41 In RPE cells, caspase 3 was strongly activated after infection with H5N1. Low (H3N2) or no (H1N1) caspase 3 was activated after infection with seasonal influenza A viruses (data not shown). It remains unclear whether the inability of seasonal influenza A virus strains to activate caspase 3 contributes to the nonpermissiveness of RPE cells to these virus strains or whether it rather is a consequence of this nonpermissiveness.
Pretreatment with type I and II interferons inhibited H5N1 replication in RPE cells. H5N1 viruses were initially found to be insensitive to inhibition by type I interferons. 42, 43 However, findings by other groups challenged these conclusions. [35] [36] [37] 44 As shown in the present study, pretreatment with type I and II interferons interfered with H5N1 replication in RPE cells. Moreover, A549 cells resembling human alveolar type II epithelial cells were also protected by type I and II interferons from H5N1 infection. These findings favor a potential role of interferons as treatment options in the case of H5N1 pandemic.
Virus infection of RPE cells was previously shown to result in an interferon response that may limit virus replication. 23 The NS1 proteins of H5N1 viruses have been reported to better inhibit a cellular interferon response than do NS1 proteins of seasonal influenza A viruses. 42, 43 Therefore, differences in the ability of H5N1 NS1 proteins and NS1 proteins of seasonal influenza strains may contribute to the different influenza A virus replication kinetics in RPE cells observed herein. Addition of interferons after infection resulted in strongly decreased antiviral effects of interferons (data not shown). Moreover, infection of RPE cells with H1N1-induced MxA expression and phosphorylation of STAT1 and -2 indicating induction of interferon signaling, whereas RPE cell infection with H5N1 did not (data not shown). This result may indicate that H5N1 viruses are very efficient in antagonizing the interferon response once an RPE cell is infected, although they remain sensitive to pretreatment with interferons.
Elevated levels of different cytokines/chemokines (hypercytokinemia), detected in the blood of humans infected with H5N1 strains, were suggested to contribute to the pathogenesis of H5N1 disease. Since serum cytokine/chemokine levels do not necessarily reflect the local production of these regulatory proteins in the lungs or other infected tissues, it is important to study the effects of H5N1 on cytokine/ chemokine expression in specific cell types of infected tissues. 6 Proinflammatory gene expression may be altered in cells from immune-privileged sites, such as RPE cells. 10 Elevated levels of TNF-␣, CXCL8 (also known as interleukin 8, IL-8), CXCL10 (also known as interferon ␥-inducible protein 10, IP-10), and/or IL-6 were detected in the plasma of H5N1-infected humans. 6 Influenza A virus infection of human blood dendritic cells has been shown to trigger CXCL11 (interferon ␥-inducible protein 9, IP-9) production by these cells. 45 H5N1 infection of RPE cells enhanced expression of all five cytokines. Expression patterns of proinflammatory molecules differ between macrophages and airway epithelial cells, as indicated by experiments using cultured cells as well as by pathologic examination of the lung of a patient who died of H5N1 influenza. 46 -49 Proinflammatory gene expression in H5N1-infected RPE cells more closely resembles that of infected macrophages. For example, TNF-␣, IL-8, and IL-6 were found to be upregulated in H5N1-infected RPE cells and macrophages but not in airway epithelial cells. Ribavirin inhibited upregulation of all five investigated cytokines in RPE cells in a concentration-dependent manner. These data suggest that H5N1 infection of RPE cells results in a proinflammatory response that can at least in part be impeded by antiviral therapy.
In conclusion, we showed that primary human RPE cells are permissive to H5N1 influenza virus replication. Therefore, RPE cells represent a model for the study of H5N1 influenza virus biology in cells derived from the CNS. Moreover, our data warrant further study of the role of influenza virus replication in retinal diseases associated with influenza A virus infections. 
